Protection of the Human Gut Microbiome From Antibiotics/Experiment 1/Signature 1
From BugSigDB
Needs review
Source: Supplementary table 3, Supplementary figure 1
Description: A detailed analysis of the MGSs that differed significantly between treatment groups
Abundance in Group 1: increased abundance in moxifloxacin treated group (MXF)
| NCBI | Quality Control | Links |
|---|---|---|
| Archaea | ||
| Blautia |
Revision editor(s): WikiWorks
